mSCF-based gene therapy (Celladon)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamemSCF-based gene therapy (Celladon)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionStem cell growth factor receptor inhibitors

TargetsStem cell growth factor receptor

Therapy Area/IndicationsMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelladon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelladon

Active IndicationsN/A

Inactive IndicationsMyocardial Ischemia

ATC CodeN/A